Faecal extraction systems market seen reaching $2.21B by 2030

The faecal extraction systems market is projected to grow from $1.7 billion in 2025 to $1.79 billion in 2026, with demand tied to gastrointestinal disease testing, lab expansion and broader use of biomarker assays. North America led the market in 2025, while The Business Research Company expects steady global growth through 2030.

Why it matters: - Faecal extraction systems support stool sample collection for detecting pathogens, microbes and parasite components. - The market is tied to disease diagnosis, treatment monitoring and broader preventive testing. - Rising use of these systems reflects growing demand for more accurate gastrointestinal testing.

What happened: - The Business Research Company published its Faecal Extraction Systems Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The market was valued at $1.7 billion in 2025 and is projected to reach $1.79 billion in 2026. - The report forecasts the market will grow to $2.21 billion by 2030. - The report cites a 5.5% CAGR for 2026 and a 5.4% CAGR through 2030. - The report says North America was the largest regional market in 2025. - The geographic coverage also includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available. - The full market report is available online.

The details: - Growth drivers include higher incidence of gastrointestinal infections, expansion of diagnostic laboratory networks, wider use of fecal biomarker testing, growth in parasitic disease screening and stronger clinical awareness of gut health. - Future demand is expected to come from early disease detection, investments in advanced diagnostic assays, growth in outpatient diagnostic services, preventive healthcare and automated laboratory workflows. - Expected market trends include automated sample collection systems, rapid stool diagnostic tests, immunological and molecular assays, point-of-care testing and a stronger focus on diagnostic reliability and hygiene. - The report defines a faecal extraction system as a device or tool used to collect stool samples for identifying pathogens, microbes or parasite components. - These systems are used to diagnose gastrointestinal conditions through accurate and safe faecal sample collection for laboratory analysis. - North America leads because of established healthcare infrastructure, extensive diagnostic facilities and high awareness of gastrointestinal health issues. - The report’s additional features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables.

Between the lines: - The market’s growth profile points to steady, not explosive, expansion, driven by recurring clinical need rather than one-off demand. - The emphasis on automation, rapid tests and point-of-care options suggests laboratories are prioritizing speed, workflow efficiency and contamination control. - The IBD data shows one of the strongest underlying demand signals comes from chronic disease management, not just acute infection testing.

What's next: - Demand is likely to rise as laboratories adopt more automated collection and testing workflows. - The shift toward earlier detection and preventive care should keep stool-based diagnostics central to future demand. - IBD prevalence is expected to continue increasing, which should support ongoing use of faecal extraction systems in clinical settings. - The IBD Clinical and Research Centre expects more than 470,000 Canadians, or 1.1% of the population, to live with IBD by 2035.

The bottom line: - Faecal extraction systems are moving from a niche diagnostic accessory to a core part of gastrointestinal testing, with North America leading and chronic disease screening driving much of the demand.